Direktorat Registrasi ObatValid

SIFROL ER

Claim this product
BPOM Number
DKI2124200314A1
Approved
21 November 2024
Expiry
5 November 2025
Form
TABLET PELEPASAN LAMBAT; 0,375 mg

About This Registration

SIFROL ER is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2124200314A1. Its current registration status is Valid, with the licence valid until 5 November 2025. The product is registered to BOEHRINGER INGELHEIM INDONESIA - INDONESIA. BPOM first approved this registration in August 2021. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 3 ALUBLISTER @ 10 TABLET PELEPASAN LAMBAT
Department
Direktorat Registrasi Obat
Data Last Updated
13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Ingredients (1)

PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE

Market Intelligence

Owner Portfolio
BOEHRINGER INGELHEIM INDONESIA - INDONESIA holds 80 BPOM registrations
Manufacturer Scale
BOEHRINGER INGELHEIM INDONESIA - INDONESIA produces 80 registered products
Registration Age
Registered for 5 years
Expiry Status
Expired 277 days ago

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from BOEHRINGER INGELHEIM INDONESIA - INDONESIA

SIFROL

-DKI0252501510A1
Valid
Approved: Sep 2, 2022TABLET; 0.125 MG
View product →

PEGASYS

-DKI1057506043A1
Valid
Approved: Mar 8, 2020INJEKSI; 135 MCG
View product →

SIFROL ER

-DKI2124200314A1
Valid
Approved: Aug 4, 2021TABLET PELEPASAN LAMBAT; 0,375 mg
View product →

CATAPRES

-DKI1592600610B1
Valid
Approved: Sep 22, 2019TABLET; 0,15 MG
View product →

JARDIANCE

-DKI2124200417B1
Valid
Approved: Sep 11, 2021TABLET SALUT SELAPUT; 25 MG
View product →

Products in the same class

TAXEF

-DKL0319925644A1
Valid
Approved: Mar 31, 2026SERBUK INJEKSI
PHAPROS TBK
View product →

CLOPIDOGREL BISULFATE

-GKL1740809417A2
Valid
Approved: Mar 18, 2026TABLET SALUT SELAPUT
INFION - INDONESIA
View product →

FALERGI

-DTL0131521717A1
Valid
Approved: Jan 15, 2026TABLET SALUT SELAPUT
PRATAPA NIRMALA - INDONESIA
View product →

AMPICILLIN SODIUM

-GKL2117630144A1
Valid
Approved: Jan 5, 2026SERBUK INJEKSI
INTERBAT - INDONESIA
View product →

DOMILIUM

-DKL0807118933A1
Valid
Approved: Dec 15, 2025SUSPENSI
PERUSAHAAN INDUSTRI FARMASI DAN DAGANG FIRST MEDIPHARMA - INDONESIA
View product →
1